Bentham Science Logo

Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 19, 3 Issues, 2019
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access

Most Cited Articles

Review Article

Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis; from pathophysiology to clinical practice

, 2018; 18(2): 139-146.

Dimitrios Patoulias*, Alexandros Manafis, Christos Mitas, Konstantinos Avranas, Georgios Lales, Ioanna Zografou, Christos Sambanis and Asterios Karagiannis

DOI: 10.2174/1871529X18666180206123149

Review Article

Nanoparticle based treatment for cardiovascular diseases

, 2019; 19(1): 33-44.

Purnima Gupta, Evelyn Garcia, Amrita Sarkar, Sumit Kapoor, Khadija Rafiq, Hitendra S. Chand and Rahul Dev Jayant*

DOI: 10.2174/1871529X18666180508113253

Review Article

Sodium-glucose cotransporter 2 inhibitors: Glucose lowering against other hypoglycemic agents

, 2018; 18(2): 94-103.

Konstantinos Avranas*, Konstantinos Imprialos, Konstantinos Stavropoulos, Georgios Lales, Alexandos Manafis, Anastasia Skalkou and Lars Kihm

DOI: 10.2174/1871529X18666180206160838

Review Article

Immunomodulatory and anti-inflammatory effects of thymoquinone

, 2018; 18(1): 52-60.

Hanieh Shaterzadeh-Yazdi, Mohammad-Foad Noorbakhsh, Farzad Hayati, Saeed Samarghandian* and Tahereh Farkhondeh

DOI: 10.2174/1871529X18666180212114816

Review Article

Sodium-glucose cotransporter 2 inhibitors: Nephroprotective impact on diabetic kidney disease

, 2018; 18(2): 120-126.

Konstantinos Stavropoulos*, Konstantinos P. Imprialos, Nikiforos Stavropoulos, Sofia Bouloukou, Georgios Kerpiniotis, Kyriakos Dimitriadis, Constantinos Tsioufis and Michael Doumas

DOI: 10.2174/1871529X18666180206155349

General Review Article

Platelet activation polymorphisms in ischemia

, 2018; 18(2): 153-161.

Habib Haybar, Elahe Khodadi, Kazem Zibara and Najmaldin Saki*

DOI: 10.2174/1871529X18666180326121239

Review Article

Sodium-glucose cotransporter 2 inhibitors: Impact on body weight and blood pressure compared with other antidiabetic drugs

, 2018; 18(2): 104-113.

Konstantinos P. Imprialos*, Konstantinos Stavropoulos, Nikiforos Stavropoulos, Dimitrios Patoulias, Konstantinos Petidis, Charalampos Grassos, Kyriakos Dimitriadis and Constantinos Tsioufis

DOI: 10.2174/1871529X18666180206144342

General Review Article

What genetics tells us about cardiovascular disease in diabetic patients?

, 2018; 18(2): 147-152.

Habib Haybar, Mohammad Taha Jalali and Zeinab Deris Zayeri*

DOI: 10.2174/1871529X18666180212114305

Review Article

Sodium-glucose cotransporter 2 inhibitors: The pleiotropic mechanisms of actions

, 2018; 18(2): 86-93.

Panteleimon Pantelidis*, Andreas Kalliakmanis, Christos Mitas, Michail Sideris, Charalampos Grassos, Andreas Pittaras and Athanasios Manolis

DOI: 10.2174/1871529X18666180206130218

Review Article

Sodium-glucose cotransporter 2 inhibitors: Potential cardiovascular and mortality benefits

, 2018; 18(2): 114-119.

Dragan Lovic*, Andreas Pittaras, Manolis Kallistratos, Constantinos Tsioufis, Charalampos Grassos, Dragan Djordjevic, Ivan Tasic and Athanasios Manolis

DOI: 10.2174/1871529X18666180227102137

Review Article

Sodium-glucose cotransporter 2 inhibitors and ischemic stroke

, 2018; 18(2): 134-138.

Dimitrios Milonas and Konstantinos Tziomalos*

DOI: 10.2174/1871529X18666180206120444


Garry X. Shen
University of Manitoba
Winnipeg, MB

Biography View Full Editorial Board

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
Track Your Manuscript:

Scopus CiteScore Metrics: 1.30

New eBook

Frontiers in Clinical Drug Research-Hematology

You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog